Conmed (CNMD) Depreciation & Amortization (CF) (2010 - 2026)

Conmed's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 1.44% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.1 million (up 1.71% YoY) and the FY2025 annual result came in at $17.1 million, up 3.24% from the prior year.
• Depreciation & Amortization (CF) was $4.2 million for Q1 2026 at Conmed, up from $4.1 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $4.5 million in Q2 2025 and bottomed at $3.9 million in Q3 2023.
• A 5-year average of $4.1 million and a median of $4.1 million in 2025 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) dropped 15.24% — and 2025, when it increased 7.23%.
• Conmed's Depreciation & Amortization (CF) stood at $4.0 million in 2022, then climbed by 0.62% to $4.1 million in 2023, then increased by 3.63% to $4.2 million in 2024, then decreased by 3.17% to $4.1 million in 2025, then advanced by 2.66% to $4.2 million in 2026.
• Business Quant data shows CNMD's Depreciation & Amortization (CF) at $4.2 million in Q1 2026, $4.1 million in Q4 2025, and $4.4 million in Q3 2025.